Population Pharmacokinetic Study of Prophylactic Fluconazole in Preterm Infants for Prevention of Invasive Candidiasis
Author(s) -
Yu Kyong Kim,
Ju Young Lee,
Jaeseong Oh,
Sujin Rhee,
Seung Han Shin,
Seo Hyun Yoon,
SeungHwan Lee,
HanSuk Kim,
KyungSang Yu
Publication year - 2019
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01960-18
Subject(s) - fluconazole , pharmacokinetics , medicine , volume of distribution , population , dosing , regimen , nonmem , pharmacology , antifungal , environmental health , dermatology
Fluconazole is an antifungal agent with reported evidence for its prophylactic effect against systemic fungal infection in preterm infants. The aim of this study was to build a population pharmacokinetic model to evaluate the pharmacokinetic characteristics of intravenous and oral fluconazole in preterm infants with the current prophylactic fluconazole dosing regimen.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom